According to Compugen's latest financial reports the company's total liabilities are $55.77 M. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-12-31 | $55.77 M | 238.11% |
2022-12-31 | $16.49 M | -35.23% |
2021-12-31 | $25.47 M | 37.42% |
2020-12-31 | $18.53 M | 20.02% |
2019-12-31 | $15.44 M | -3.11% |
2018-12-31 | $15.93 M | 68.66% |
2017-12-31 | $9.44 M | 24% |
2016-12-31 | $7.62 M | -19.02% |
2015-12-31 | $9.41 M | 6.09% |
2014-12-31 | $8.87 M | -64.27% |
2013-12-31 | $24.82 M | 120.9% |
2012-12-31 | $11.23 M | 18.28% |
2011-12-31 | $9.5 M | 16.24% |
2010-12-31 | $8.17 M | 193.25% |
2009-12-31 | $2.78 M | -34.28% |
2008-12-31 | $4.24 M | -3.2% |
2007-12-31 | $4.38 M | -14.4% |
2006-12-31 | $5.11 M | -12.63% |
2005-12-31 | $5.85 M | 1.23% |
2004-12-31 | $5.78 M | -25.02% |
2003-12-31 | $7.71 M | -7.86% |
2002-12-31 | $8.37 M | 15.9% |
2001-12-31 | $7.22 M |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
Seagen
SGEN | $1.08 B | 1,843.24% | ๐บ๐ธ USA |
Genetic Technologies GENE | $2.44 M | -95.62% | ๐ฆ๐บ Australia |
Teva Pharmaceutical Industries TEVA | $35.35 B | 63,285.03% | ๐ฎ๐ฑ Israel |
Eterna Therapeutics ERNA | $46.89 M | -15.91% | ๐บ๐ธ USA |